Samir Rashmikant Patel

Insider Reports History

Location
Vancouver, WA
Signature
/s/ Abizer Gaslightwala, as Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Samir Rashmikant Patel:

Company Role Class Num Shares Value Price $ Report Date Ownership
Akari Therapeutics Plc Director, 10%+ Owner American Depositary Shares representing Ordinary Shares 3,031,005 $3,394,726 $1.12 20 Mar 2025 PranaBio Investments LLC
Akari Therapeutics Plc Director, 10%+ Owner Ordinary Shares, par value $0.0001 per share 5,249,511,500 $3,149,707 $0.000600 03 Jan 2025 PranaBio Investments LLC
Akari Therapeutics Plc Director, 10%+ Owner Series A Warrants (Right to Buy) 406,250 $455,000 $1.12 06 Mar 2025 PranaBio Investments LLC
Akari Therapeutics Plc Director, 10%+ Owner Series B Warrants (Right to Buy) 406,250 $455,000 $1.12 06 Mar 2025 PranaBio Investments LLC
Akari Therapeutics Plc Director, 10%+ Owner Pre-Funded Warrants to purchase ADRs 618,658 $249,999 $0.4041 16 Dec 2025 Direct
Akari Therapeutics Plc Director, 10%+ Owner Pre-Funded Warrants to purchase ADRs 231,997 $93,749 $0.4041 16 Dec 2025 PranaBio Investments LLC
Akari Therapeutics Plc Director, 10%+ Owner Ordinary Shares, par value $0.0001 per share 91,396,000 $54,838 $0.000600 03 Jan 2025 Direct
Akari Therapeutics Plc Director, 10%+ Owner American Depositary Shares representing Ordinary Shares 45,698 $51,182 $1.12 20 Mar 2025 Direct
Akari Therapeutics Plc Director, 10%+ Owner Warrants to purchase American Depositary Shares ("ADRs") 618,658 16 Dec 2025 Direct
Akari Therapeutics Plc Director, 10%+ Owner Warrants to purchase ADRs 231,997 16 Dec 2025 PranaBio Investments LLC
Akari Therapeutics Plc Director, 10%+ Owner Stock Option (Right to Buy) 225,000 20 Mar 2025 Direct
CytoDyn Inc. Director Non-qualified Stock Option 12,329 24 Nov 2021 Direct

Insider Reports Filed by Samir Rashmikant Patel

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AKTX Akari Therapeutics Plc 16 Dec 2025 4 +$343,750 4 Director, 10%+ Owner 18 Dec 2025, 21:56
AKTX Akari Therapeutics Plc 20 Mar 2025 2 $0 4 Director 24 Mar 2025, 17:00
AKTX Akari Therapeutics Plc 06 Mar 2025 3 +$1,365,000 4 Director 10 Mar 2025, 17:00
AKTX Akari Therapeutics Plc 03 Jan 2025 2 +$125 4 Director 07 Jan 2025, 16:30
AKTX Akari Therapeutics Plc 26 Dec 2024 2 +$1,800 4 Director 30 Dec 2024, 16:30
AKTX Akari Therapeutics Plc 24 Dec 2024 1 +$3,750 4 Director 27 Dec 2024, 16:30
AKTX Akari Therapeutics Plc 23 Dec 2024 1 +$700 4 Director 26 Dec 2024, 16:30
AKTX Akari Therapeutics Plc 20 Dec 2024 1 +$700 4 Director 26 Dec 2024, 16:30
AKTX Akari Therapeutics Plc 30 Nov 2024 3 +$1,006,286 4 Director 03 Dec 2024, 17:50
AKTX Akari Therapeutics Plc 14 Nov 2024 1 $0 4 Director 18 Nov 2024, 20:02
AKTX Akari Therapeutics Plc 31 Oct 2024 1 $0 4 Director 01 Nov 2024, 18:00
AKTX Akari Therapeutics Plc 30 Sep 2024 1 $0 4 Director 02 Oct 2024, 18:34
AKTX Akari Therapeutics Plc 30 Jun 2024 1 $0 4 Director 02 Jul 2024, 16:30
AKTX Akari Therapeutics Plc 31 May 2024 2 +$2,387,264 4 Director 04 Jun 2024, 16:45
AKTX Akari Therapeutics Plc 01 Jan 2024 0 $0 3 Director 02 Jan 2024, 19:56
CYDY CytoDyn Inc. 24 Nov 2021 6 $0 4/A Director 30 Nov 2021, 17:31
CYDY CytoDyn Inc. 18 Oct 2021 1 $0 4 Director 20 Oct 2021, 16:10